This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (183)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Alert me on articles by topic  Social Bookmarking   What's this?

Hershel Jick, MD; James A. Kaye, MD, DrPH; Susan S. Jick, DSc

JAMA. 2004;292:338-343.

Context  The relation between use of antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), and suicidal ideation and behaviors has received considerable public attention recently. The use of such drugs among teenagers has been of particular concern.

Objective  To estimate the relative risks (RRs) of nonfatal suicidal behavior in patients starting treatment with 1 of 3 antidepressant drugs compared with patients starting treatment with dothiepin.

Design and Setting  Matched case-control study of patients treated in UK general practices using the UK General Practice Research Database for 1993-1999.

Participants  The base population included 159 810 users of the 4 antidepressant drugs. Participants could have used only 1 of these antidepressants and had to have received at least 1 prescription for the study antidepressant within 90 days before their index date (the date of suicidal behavior or ideation for cases and the same date for matched controls).

Main Outcome Measures  Frequency of first-time exposure to amitriptyline, fluoxetine, paroxetine, and dothiepin of patients with a recorded diagnosis of first-time nonfatal suicidal behavior or suicide compared with comparable patients who did not exhibit suicidal behavior.

Results  After controlling for age, sex, calendar time, and time from first antidepressant prescription to the onset of suicidal behavior, the relative risks for newly diagnosed nonfatal suicidal behavior in 555 cases and 2062 controls were 0.83 (95% confidence interval, [CI] 0.61-1.13) for amitriptyline, 1.16 (95% CI, 0.90-1.50) for fluoxetine, and 1.29 (95% CI, 0.97-1.70) for paroxetine compared with those using dothiepin. The RR for suicidal behavior among patients first prescribed an antidepressant within 1 to 9 days before their index date was 4.07 (95% CI, 2.89-5.74) compared with patients who were first prescribed an antidepressant 90 days or more before their index date. Time since first antidepressant prescription was not, however, a confounder of the relation between specific antidepressants and suicidal behavior since its relation to suicidal behavior was not materially different among users of the 4 study drugs. Similarly for fatal suicide, the RR among patients who were first prescribed an antidepressant within 1 to 9 days before their index date was 38.0 (95% CI, 6.2-231) compared with those who were first prescribed an antidepressant 90 days or more before their index date. There were no significant associations between the use of a particular study antidepressant and the risk of suicide.

Conclusions  The risk of suicidal behavior after starting antidepressant treatment is similar among users of amitriptyline, fluoxetine, and paroxetine compared with the risk among users of dothiepin. The risk of suicidal behavior is increased in the first month after starting antidepressants, especially during the first 1 to 9 days. A possible small increase in risk (bordering statistical significance) among those starting the newest antidepressant, paroxetine, is of a magnitude that could readily be due to uncontrolled confounding by severity of depression. Based on limited information, we also conclude that there is no substantial difference in effect of the 4 drugs on people aged 10 to 19 years.

Author Affiliations: Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Antidepressants and the Risk of Suicidal Behaviors
Corrado Barbui
JAMA. 2004;292(23):2833.
EXTRACT | FULL TEXT  

Antidepressants and the Risk of Suicidal Behaviors
Iradj Maany
JAMA. 2004;292(23):2833.
EXTRACT | FULL TEXT  

Antidepressants and the Risk of Suicidal Behaviors—Reply
Hershel Jick, James A. Kaye, and Susan S. Jick
JAMA. 2004;292(23):2833.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Suicide Risk and the SSRIs
Simon Wessely and Robert Kerwin
JAMA. 2004;292(3):379-381.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Service Implications of Providing Intensive Monitoring During High-Risk Periods for Suicide Among VA Patients With Depression
Valenstein et al.
Psychiatr. Serv. 2009;60:439-444.
ABSTRACT | FULL TEXT  

Migraine and suicidal ideation in adolescents aged 13 to 15 years
Wang et al.
Neurology 2009;72:1146-1152.
ABSTRACT | FULL TEXT  

Are Patients With Depression at Heightened Risk of Suicide as They Begin to Recover?
Mittal et al.
Psychiatr. Serv. 2009;60:384-386.
ABSTRACT | FULL TEXT  

Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies
Barbui et al.
CMAJ 2009;180:291-297.
ABSTRACT | FULL TEXT  

Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians
Qaseem et al.
ANN INTERN MED 2008;149:725-733.
ABSTRACT | FULL TEXT  

Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
Gartlehner et al.
ANN INTERN MED 2008;149:734-750.
ABSTRACT | FULL TEXT  

Antidepressants and Suicidal Behavior: Cause or Cure?
Brent
Focus 2008;6:366-367.
FULL TEXT  

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson et al.
J Psychopharmacol 2008;22:343-396.
ABSTRACT  

Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Laje et al.
Focus 2008;6:69-79.
ABSTRACT | FULL TEXT  

Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Simon and Savarino
Focus 2008;6:80-85.
ABSTRACT | FULL TEXT  

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management
Cheung et al.
Pediatrics 2007;120:e1313-e1326.
ABSTRACT | FULL TEXT  

Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Laje et al.
Am. J. Psychiatry 2007;164:1530-1538.
ABSTRACT | FULL TEXT  

Antidepressants and Suicidal Behavior: Cause or Cure?
Brent
Am. J. Psychiatry 2007;164:989-991.
FULL TEXT  

Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Simon and Savarino
Am. J. Psychiatry 2007;164:1029-1034.
ABSTRACT | FULL TEXT  

Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets
Gibbons et al.
Am. J. Psychiatry 2007;164:1044-1049.
ABSTRACT | FULL TEXT  

Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study
Perlis et al.
Arch Gen Psychiatry 2007;64:689-697.
ABSTRACT | FULL TEXT  

The Effect of Antidepressant Warnings on Prescribing Trends in Ontario, Canada
Kurdyak et al.
AJPH 2007;97:750-754.
ABSTRACT | FULL TEXT  

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study
Rubino et al.
BMJ 2007;334:242-242.
ABSTRACT | FULL TEXT  

Restrictions on Antidepressant Medications for Children: A Review of Medicaid Policy
Fischer et al.
Psychiatr. Serv. 2007;58:135-138.
ABSTRACT | FULL TEXT  

Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort
Tiihonen et al.
Arch Gen Psychiatry 2006;63:1358-1367.
ABSTRACT | FULL TEXT  

US Suicide Rates by Age Group, 1970-2002: An Examination of Recent Trends
McKeown et al.
AJPH 2006;96:1744-1751.
ABSTRACT | FULL TEXT  

No apparent difference in suicide risk between older and newer antidepressants although older drugs may increase risk of suicide attempt during the first month of treatment.
Ebmeier
Evid. Based Ment. Health 2006;9:82-82.
FULL TEXT  

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression.
Zarate et al.
Arch Gen Psychiatry 2006;63:856-864.
ABSTRACT | FULL TEXT  

Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.
Olfson et al.
Arch Gen Psychiatry 2006;63:865-872.
ABSTRACT | FULL TEXT  

Adolescent Suicidal Ideation as Predictive of Psychopathology, Suicidal Behavior, and Compromised Functioning at Age 30
Reinherz et al.
Am. J. Psychiatry 2006;163:1226-1232.
ABSTRACT | FULL TEXT  

Media pressure and patient care
Blier
J Psychopharmacol 2006;20:469-470.
 

The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly
Juurlink et al.
Am. J. Psychiatry 2006;163:813-821.
ABSTRACT | FULL TEXT  

Suicidal risk in antidepressant drug trials.
Baldessarini et al.
Arch Gen Psychiatry 2006;63:246-248.
FULL TEXT  

Case reports of suspected adverse drug reactions: case reports generate signals efficiently.
Russmann
BMJ 2006;332:488-488.
FULL TEXT  

Recognizing and treating depression in children and adolescents
Dopheide
Am J Health Syst Pharm 2006;63:233-243.
ABSTRACT | FULL TEXT  

Suicide Risk During Antidepressant Treatment
Simon et al.
Am. J. Psychiatry 2006;163:41-47.
ABSTRACT | FULL TEXT  

Opening Pandora's Pillbox: Using Modern Information Tools To Improve Drug Safety
Gottlieb
Health Aff (Millwood) 2005;24:938-948.
ABSTRACT | FULL TEXT  

Whither "chronic prostatitis"?
Luzzi
Sex. Transm. Infect. 2005;81:96-97.
FULL TEXT  

Suicide, depression, and antidepressants
Cipriani et al.
BMJ 2005;330:373-374.
FULL TEXT  

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
Gunnell et al.
BMJ 2005;330:385.
ABSTRACT | FULL TEXT  

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study
Martinez et al.
BMJ 2005;330:389.
ABSTRACT | FULL TEXT  

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
Fergusson et al.
BMJ 2005;330:396.
ABSTRACT | FULL TEXT  

Other articles noted
Evid. Based Ment. Health 2005;8:3-4.
FULL TEXT  

Abstracts FOR MAJOR DEPRESSIVE DISORDER
Focus 2005;3:54-60.
FULL TEXT  

Antidepressants and the Risk of Suicidal Behaviors
Barbui
JAMA 2004;292:2833-2833.
FULL TEXT  

Antidepressants and the Risk of Suicidal Behaviors
Maany
JAMA 2004;292:2833-2833.
FULL TEXT  

Telephone Psychotherapy and Care Management for Depression
Tanvetyanon
JAMA 2004;292:2720-2720.
FULL TEXT  

A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database
Murray et al.
Arch. Dis. Child. 2004;89:1098-1102.
ABSTRACT | FULL TEXT  

Selective serotonin reuptake inhibitors
Geddes and Cipriani
BMJ 2004;329:809-810.
FULL TEXT  

Review of Child and Adolescent Psychiatry
Naqvi
Focus 2004;2:529-540.
ABSTRACT | FULL TEXT  

Suicide Attempts and Antidepressants
JWatch Women's Health 2004;2004:12-12.
FULL TEXT  

SSRIs Not Associated with Increased Risk for Suicidal Behavior
JWatch Emergency Med. 2004;2004:8-8.
FULL TEXT  

Antidepressants and suicide: Risk of completed suicide is not the same as risk of deliberate self harm
Mitchell
BMJ 2004;329:461-461.
FULL TEXT  

Antidepressants and Suicidality: The First Few Weeks Are Crucial
JWatch Psychiatry 2004;2004:3-3.
FULL TEXT  

Treatment of Adolescents With Major Depression: Contributions of a Major Trial
Glass
JAMA 2004;292:861-863.
FULL TEXT  

Another Look at Suicide Risk with Antidepressant Use
JWatch General 2004;2004:3-3.
FULL TEXT  

Suicide Risk and the SSRIs
Wessely and Kerwin
JAMA 2004;292:379-381.
FULL TEXT